FDA approves Ozempic to reduce risks from chronic kidney disease in diabetes patients
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the U.S. Food and Drug Administration to reduce certain risks associated with ...
JD Supra5h
Clinicaltrials.gov: Recent Action May Signal Increased Attention from FDA on Trial Data Reporting Compliance
The US Food and Drug Administration (FDA) recently issued a notice of noncompliance to the FADOI Foundation, citing the ...